专利摘要:
The present invention describes copolymer particles of styrene and methyl methacrylate functionalized on its surface with polyethylene glycol methacrylate. This material allows the immobilization on its surface of proteins through covalent binding. The invention describes the process for obtaining the particles and their use in the elimination of toxic compounds present in the blood refractory to dialysis treatments, such as excess bilirubin. The invention also writes dialysis cartridges containing the functionalized particles bound to proteins such as albumin, compatible with the current dialysis systems. (Machine-translation by Google Translate, not legally binding)
公开号:ES2691146A1
申请号:ES201731386
申请日:2017-12-05
公开日:2018-11-23
发明作者:Juan Francisco Rodríguez Romero;Antonio De Lucas Martínez;Manuel Salvador Carmona Franco;Ana María BORREGUERO SIMÓN;Francisco Javier REDONDO CALVO;David PADILLA VALVERDE;María Del Prado GARRIDO MARTÍN
申请人:Universidad de Castilla La Mancha;
IPC主号:
专利说明:

image 1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image12
image13
image14
image15
image16
image17
image18
image19
权利要求:
Claims (1)
[1]
image 1
image2
image3
类似技术:
公开号 | 公开日 | 专利标题
EA201892691A1|2019-04-30|SINGLE-DOMAIN PROTEIN, BINDING SERUM ALBUMIN
JOP20190009A1|2017-06-16|Antibodies against signal-regulatory protein alpha and methods of use
CY1116970T1|2017-04-05|FKBP-L AND THEIR USES AS VASCULAR ANTIBODIES
BR112016029123A2|2017-08-22|lymphoma treatment
ECSP12012272A|2012-11-30|PROTEINS THAT JOIN TNF-?
UA120847C2|2020-02-25|Interleukin-2 fusion proteins and uses thereof
EA202090739A1|2020-09-07|PROTEINS BINDING ANTIGEN OF MATURING B-CELLS
EA201991168A1|2019-12-30|PROTEIN BINDING PROSTATIC SPECIFIC MEMBRANE ANTIGEN
BR112017020986A2|2018-08-14|recombinant binding proteins and their use
CL2008003366A1|2009-05-29|Compounds derived from fused nitrogen heterocycles, mek and mapk / erk protein kinase inhibitors; compound preparation process; pharmaceutical composition comprising them; set that includes them; and its use in the preparation of medicaments for the treatment of hyperproliferative disorders.
EA202090216A3|2020-07-31|BINDERS SERUM ALBUMIN DOMAINS FIBRONECTIN TYPE III
NZ741586A|2021-11-26|New polypeptide having affinity to pd-l1
GB2431403A|2007-04-25|Capture and removal of biomolecules from body fluids using partial molecular imprints
TN2018000419A1|2020-06-15|Antibodies specific for hyperphosphorylated tau and methods of use thereof.
BR112015022967A8|2018-01-23|high affinity anti-gd2 antibodies.
WO2018226578A8|2019-05-31|Nectin-4 binding proteins and methods of use thereof
EA201792193A1|2018-05-31|CONSTRUCTIONS OF BISPECIFIC ANTIBODIES FOR CDH3 AND CD3
EP2853895A3|2015-04-15|Methods, apparatus and systems for detection of total protein using capillary electrophoresis
MX2016000063A|2016-03-01|Affinity chromatography matrix.
CL2008003357A1|2011-01-07|Process for obtaining a solution of human albumin with high capacity of molecule binding comprising a diafiltration, stabilization with nacl and amino acids without the addition of fatty acids, pasteurization and a second diafiltration.
WO2018069871A3|2018-07-19|Anti-kras binding proteins
EP2765140A3|2015-06-03|Cadherin-2 or Mucin-13 binding molecules for cancer treatment
Dominik et al.2014|Reduction of Elevated Cytokine Levels in A cute/A cute‐on‐Chronic Liver Failure Using Super‐Large Pore Albumin Dialysis Treatment: An In Vitro Study
ES2540026B1|2016-04-13|Functionalization of magnetic particles by nucleophilic substitution of organic halides
WO2019094533A8|2020-04-16|Angptl8-binding agents and methods of use thereof
同族专利:
公开号 | 公开日
ES2691146B2|2019-05-17|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题

法律状态:
2018-11-23| BA2A| Patent application published|Ref document number: 2691146 Country of ref document: ES Kind code of ref document: A1 Effective date: 20181123 |
2019-05-17| FG2A| Definitive protection|Ref document number: 2691146 Country of ref document: ES Kind code of ref document: B2 Effective date: 20190517 |
优先权:
申请号 | 申请日 | 专利标题
ES201731386A|ES2691146B2|2017-12-05|2017-12-05|FUNCTIONALIZED PARTICLES OF PROTEIN LIGANTS, METHOD OF OBTAINING AND CARTRIDGES OF DIALYSIS CONTAINING SUCH PARTICLES|ES201731386A| ES2691146B2|2017-12-05|2017-12-05|FUNCTIONALIZED PARTICLES OF PROTEIN LIGANTS, METHOD OF OBTAINING AND CARTRIDGES OF DIALYSIS CONTAINING SUCH PARTICLES|
[返回顶部]